Basit öğe kaydını göster

dc.contributor.authorOrta, T
dc.contributor.authorOzar, MOK
dc.date.accessioned2021-03-04T08:07:36Z
dc.date.available2021-03-04T08:07:36Z
dc.date.issued2005
dc.identifier.citationOzar M., Orta T., "The use of chromosome aberrations in predicting breast cancer risk", JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, cilt.24, sa.2, ss.217-222, 2005
dc.identifier.issn0392-9078
dc.identifier.othervv_1032021
dc.identifier.otherav_61b3e1ef-4d00-45b7-a3ff-4c51e726d4d6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/68087
dc.description.abstractIn order to assess the usefulness of chromosome aberrations in predicting breast cancer risk, 10 patients with breast cancer diagnosis and appropriately matching 10 healthy controls were chosen. Spontaneous and radiation induced unstable chromosome aberrations in peripheral blood lymphocytes were compared in the two groups. When the spontaneous aberration frequencies were compared, acentric chromosome frequency, scored in the group of patients was significantly higher than that found in the control group (p < 0.01). Absolute aberration frequencies as a determinant of radiosensitivity were calculated by subtracting spontaneous aberration frequencies from the frequencies that were obtained following 2 Gy of Co-60 gamma irradiation. Absolute dicentric chromosome frequency significantly increased in the patients' group (p < 0.01) as compared to that observed in the control group. Increases in either spontaneous acentric chromosome frequency or dicentric chromosome frequency as a determinant of an enhanced radiosensitivity in the group of patients may be valuable in predicting breast cancer risk. The studies involving unstable chromosome aberrations can be easily performed and can facilitate cancer diagnosis with minor effort and low cost.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.titleThe use of chromosome aberrations in predicting breast cancer risk
dc.typeMakale
dc.relation.journalJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
dc.contributor.department, ,
dc.identifier.volume24
dc.identifier.issue2
dc.identifier.startpage217
dc.identifier.endpage222
dc.contributor.firstauthorID175217


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster